CWM
ETON icon

Centric Wealth Management’s Eton Pharmaceutcials ETON Stock Holding History

Centric Wealth Management’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-28,000
Closed -$202K – 122
2019
Q4 		$202K Buy
+28,000
New +$173K 0.16% 95

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Centric Wealth Management's ETON Position: Q1 2020 in Review

Centric Wealth Management sold out of Eton Pharmaceutcials (ETON) in Q1 2020, closing a stake of 28,000 shares — an estimated $202K sold.

Centric Wealth Management first reported a position in ETON in Q4 2019 and held it in 1 quarter. The position peaked at $202K in Q4 2019. 17 funds tracked by Wall St. Rank hold ETON as of Q1 2020.

  • Centric Wealth Management reported no remaining Eton Pharmaceutcials position as of Q1 2020 after selling out during the quarter.
  • Centric Wealth Management sold 28,000 Eton Pharmaceutcials shares in Q1 2020, an estimated $202K.
  • Centric Wealth Management first reported a position in Eton Pharmaceutcials in Q4 2019 and held it in 1 quarter.
  • Centric Wealth Management's Eton Pharmaceutcials position peaked at $202K in Q4 2019.
  • 17 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2020.

Based on Centric Wealth Management's 13F filing for Q1 2020, filed 8 Apr 2020.